Navigation Links
XTL Biopharmaceuticals Implements Restructuring Plan
Date:12/8/2008

VALLEY COTTAGE, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that it is restructuring its operations following the failure of the Bicifadine Phase 2b clinical trial. The company is terminating the employment of 9 employees, representing 75% of its workforce. The remaining employees will be responsible for seeking potential assets or a company to merge into XTL, or for assisting in the liquidation and/or disposition of XTL's assets.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future business prospects, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. It is possible that we will not be able to find a buyer for the assets or a merger partner. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.xtlbio.com . The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstC...ading supplier of innovative products for processi...sults for the first quarter of fiscal 2010. ,, ...any reported revenues of $5.2 million, a 15 percen...rst quarter a year ago. The Company said the key c...
(Date:11/5/2009)... LYNBROOK, N.Y., Nov. 5 ...a biopharmaceutical company developing first-in-cl...s financial results for the third quarter ended Se...that, in September of this year, the FDA,s Arthrit...a vote of 12-0, the approval of XIAFLEX(TM) for th...
(Date:11/5/2009)... SAN DIEGO, CA, November 5, 2009 /PRNewswire-First... focused on using proprietary taste receptor-based... for the food, beverage, and ingredient supply ind...orted financial results for the third quarter ende...for the third quarter of 2009, compared to $4.0 mi...
(Date:11/5/2009)... PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asi... BJGP ) ("BMP Sunstone" or the "Company") today an...arter 2009 financial results on,Monday, November 9...mpany will hold a conference call at 5:00 pm ET on...sults. Listeners may access the call by,dialing 1...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...l implants placed will use guided surgery ...up, WALTHAM, Mass., May 6 According to Millenniu...2008 report, the incorporation of,guided surgery t...ease,dramatically over the next few years and by 2...e advantage of some form of guided surgery,technol...
...h Programs Supported by a Grant from Otsuka ...VILLE, Md., May 6 The American Psychiatric,Founda... and one individual,as the recipients of the fifth...ealth. The awards were presented at the 2008 APF A...n or individual was presented a plaque,along with ...
...rex, Inc. (Nasdaq:,MEDX) announced today that it i... Healthcare Conference at 1:00 p.m. EDT on Tuesday...will be available in the Investor,Relations sectio...m . An archived,edition of the presentation will b... Medarex is a biopharmaceutical company focused on...
Other Biology Technology:Guided Surgery Technology Gaining Popularity in the Dental Implant Market 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:11/4/2009)...deciphered the DNA codes, or genomes, of the famed...ed The Genome 10K Project, an international effort...s on 10,000 species of animals for conducting comp...be achieved. , Participating in The Genome 10K p... 5, 2009 issue of the Journal of Heredity , are 7...
(Date:11/4/2009)...RNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE... biometrics software, today reported financial res...09. ,, Michael Tzannes, Aware,s Chairman and ...announced an agreement to sell our DSL and home ne...miconductor company being spun out of Infineon. T...
(Date:11/4/2009)... at the University of North Carolina at Chapel Hil...nia, San Francisco have developed and experimental...es for existing drugs. , The researchers develop...r the structures of all known drugs are to the nat...nds -- of disease targets within the cell. In a st...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2DaVitas Patient Centric Modalities Offer Students with Kidney Disease More Choices 56685 1DaVitas Patient Centric Modalities Offer Students with Kidney Disease More Choices 56685 2FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 1FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 2FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 3FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males 56683 4Link found between common sexual infection and risk of aggressive prostate cancer 56681 1Link found between common sexual infection and risk of aggressive prostate cancer 56681 2
... the frontier between Uganda and the Democratic Re...d in a national park and wildlife preserve on the ...cattle have settled in an adjoining Ugandan park. ...uld potentially support more than 900 individuals ...esearch but only if immediate conservation steps ...
...fornia, Davis have discovered that a prototype dru...n causes of heart failure. , Heart failure, whic...roughout the body, affects 5 million people in the...00 deaths each year. , The research in the labor... Chiamvimonvat, Department of Cardiovascular Medic...
...ty of Bath and London,s Natural History Museum has... of dinosaurs is remarkably complete. , Evolutio...n of prehistoric plants and animals: firstly they ...n chronological order according to the age of the ...ndly they observe and classify the characteristics...
Other Biology News:Research uncovers surprising lion stronghold in war-torn central Africa 2Research uncovers surprising lion stronghold in war-torn central Africa 3UC Davis research shows that newly discovered drug reduces heart enlargement 2Dinosaur fossils fit perfectly into the evolutionary tree of life 2
.... Optimized for the rapid and efficient cloning of...es traditional TA cloning approaches by offering c...any as 25-fold more positive clones.Amplicons gene...e fully compatible.High efficiency cloning, no req...
GeneAmp High Fidelity PCR from Applied Biosystems
Guanylate Cyclase Blocking Peptide from Cayman Chemical
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
Biology Products: